Investigation of changes in lens thickness depending on intravitreal administration of angiogenesis inhibitor and dexamethasone depot

Currently, the frequency of intravitreal injections (IVV) has a steady upward trend. Antiangiogenic therapy is the predominant method of treating various retinal pathologies. Intravenous injections using pharmacological drugs against VEGF, as well as the intravitreal dexamethasone implant “Ozurdex” are widely used. Since the effect of these pharmacological drugs on cataractogenesis has not yet been sufficiently studied, research in this area is of paramount importance for understanding the morphological characteristics associated with cataract progression.